APP and Alzheimer disease: Hence, to understand whether KYCCSRK peptide administration in Ts2Cje mice could impact the accumulation of AD neuropathological hallmarks in the brain, APP full length (APP), APP cleavage products (APP-C83 and APP-C99), and TAU levels and phosphorylation were evaluated.